Belite Bio Ownership | Who Owns Belite Bio?
Belite Bio Ownership Summary
Belite Bio is owned by 0.26% institutional investors, 58.60% insiders, and 41.14% retail investors. State street is the largest institutional shareholder, holding 0.05% of BLTE shares. SPDR® Portfolio Emerging Markets ETF is the top mutual fund, with 0.03% of its assets in Belite Bio shares.
BLTE Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Belite Bio | 0.26% | 58.60% | 41.14% |
Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
State street | 15.67K | 0.05% | $715.85K |
Point72 asset management | 7.31K | 0.02% | $333.97K |
Geode capital management | 6.70K | 0.02% | $306.06K |
Virtus etf advisers | 1.81K | 0.01% | $82.54K |
Gamma investing | 1.29K | 0.00% | $81.40K |
Morgan stanley | 1.04K | 0.00% | $47.69K |
Advisors preferred | 798.00 | 0.00% | $51.68K |
Mirae asset global investments | 357.00 | 0.00% | $22.12K |
Jpmorgan chase | 88.00 | 0.00% | $4.02K |
Bank of america corp /de/ | 102.00 | 0.00% | $4.66K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Virtus etf advisers | 1.81K | 0.04% | $82.54K |
Advisors preferred | 798.00 | 0.01% | $51.68K |
Gamma investing | 1.29K | 0.01% | $81.40K |
Point72 asset management | 7.31K | 0.00% | $333.97K |
Mirae asset global investments | 357.00 | 0.00% | $22.12K |
Jpmorgan chase | 88.00 | - | $4.02K |
Hrt financial lp | - | - | - |
Armistice capital | - | - | - |
Cubist systematic strategies | - | - | - |
Geode capital management | 6.70K | - | $306.06K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Advisors preferred | 798.00 | 0.01% | 798.00 |
Gamma investing | 1.29K | 0.01% | 419.00 |
Mirae asset global investments | 357.00 | 0.00% | 357.00 |
Advisor group | 8.00 | - | 3.00 |
Geode capital management | 6.70K | - | - |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Armistice capital | - | - | -148.00K |
Marshall wace, llp | - | - | -10.58K |
Hrt financial lp | - | - | -5.41K |
Morgan stanley | 1.04K | - | -5.05K |
Cubist systematic strategies | - | - | -4.79K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Advisors preferred | 798.00 | 0.01% | 798.00 | $51.68K |
Mirae asset global investments | 357.00 | 0.00% | 357.00 | $22.12K |
Sold Out
Holder | Change |
---|---|
Cubist systematic strategies | -4.79K |
Hrt financial lp | -5.41K |
Marshall wace, llp | -10.58K |
Armistice capital | -148.00K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 15 | 36.36% | 78,699 | -57.82% | - | 64.88% | 11 | 175.00% | 2 | -66.67% |
Jun 30, 2024 | 10 | -9.09% | 186,140 | 220.31% | - | 1489.38% | 3 | 50.00% | 6 | -25.00% |
Mar 31, 2024 | 11 | -35.29% | 58,112 | -62.53% | - | 63.65% | 2 | -86.67% | 8 | 700.00% |
Dec 31, 2023 | 17 | 142.86% | 155,109 | 55.74% | - | 380.68% | 15 | 200.00% | 1 | - |
Sep 30, 2023 | 7 | 16.67% | 99,593 | -90.43% | - | 1.57% | 5 | 25.00% | 1 | -50.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
SPDR® Portfolio Emerging Markets ETF | 9.98K | 0.03% | - |
SPDR® S&P Emerging Markets Small Cap ETF | 8.01K | 0.03% | - |
Fidelity Nasdaq Composite Index | 6.70K | 0.02% | - |
ActivePassive International Equity ETF | 2.43K | 0.01% | 8.00 |
SPDR® S&P China ETF | 1.52K | 0.00% | - |
Virtus LifeSci Biotech Clinical Trls ETF | 1.12K | 0.00% | - |
CIBC US Broad Market Index | 750.00 | 0.00% | - |
JHVIT Total Stock Market Index I | 486.00 | 0.00% | - |
FT Wilshire 5000 Index Instl | 146.00 | 0.00% | - |
QRG QP: Emerging Markets ADR Beta | 24.00 | 0.00% | -19.00 |
BLTE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools